Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Metabolism of 1,2-(1-/sup 14/C) dipalmitoyl phosphatidylcholine in the developing brain

Technical Report ·
OSTI ID:7065346
Thirteen-day-old rats were divided into two groups; one group received 1,2-(1-/sup 14/C) dipalmitoyl phosphatidylcholine and the other 1-/sup 14/C palmitic acid in the form of an intraperitoneal injection. One half of the total number of rats in each group were sacrificed 24 hours after injection and the other half were allowed to survive for 17 days after the injection. Radioactivity incorporated into brain and liver total lipids and individual polar lipid components of the brain was determined at both intervals. Phosphatidylcholine was isolated and partially deacylated with phospholipase A/sub 2/ from Crotalus Admanteus venom. The ratio of radioactivity FA-II/FA-I 24 hours after the injection was 8.3 when the tracer was radioactive phosphatidylcholine compared to only 0.7 when radioactive palmitate was injected. From this different labeling ratio and also different pattern of labeling of the polar lipid components it was concluded that the radioactive phosphatidylcholine was not completely deacylated before being taken up directly into the brain. Possibilities are discussed to show that the observed radioactive ratio could result from direct uptake of intact phosphatidylcholine, with little or no restriction from the blood brain barrier system, followed by partial degradation by phospholipase A/sub 1/ in the brain itself.
Research Organization:
California Univ., Los Angeles (USA). Lab. of Nuclear Medicine and Radiation Biology; California Univ., Los Angeles (USA). School of Medicine
DOE Contract Number:
AC03-76SF00012
OSTI ID:
7065346
Report Number(s):
UCLA-12-918
Country of Publication:
United States
Language:
English